Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Clinical ACO phenotypes: Description of a heterogeneous entity.

Lainez S, Court-Fortune I, Vercherin P, Falchero L, Didi T, Beynel P, Piperno D, Frappe E, Froudarakis M, Vergnon JM, Devouassoux G.

Respir Med Case Rep. 2019 Aug 27;28:100929. doi: 10.1016/j.rmcr.2019.100929. eCollection 2019.

2.

Comment from the authors: the tests combination in patients with lung cancer and malignant pleural effusion.

Brun C, Gay P, Cottier M, Karpathiou G, Patoir A, Tiffet O, Barral FG, Vergnon JM, Froudarakis ME.

J Thorac Dis. 2019 May;11(5):E74-E75. doi: 10.21037/jtd.2019.05.27. No abstract available.

3.

Removal of a mediastinal osteosynthesis screw by rigid bronchoscopy.

Vergnon JM, Huppert J.

Respir Med Res. 2019 May;75:29-31. doi: 10.1016/j.resmer.2019.02.001. Epub 2019 Apr 10. No abstract available.

PMID:
31262425
4.

Diagnostic of mediastinal lymphadenopathy in extrathoracic cancer: A place for EBUS-TBNA in real life practice?

Fournier C, Hermant C, Gounant V, Escarguel B, Thibout Y, Lachkar S, Raspaud C, Vergnon JM.

Respir Med Res. 2019 May;75:1-4. doi: 10.1016/j.resmer.2019.03.001. Epub 2019 Apr 10.

PMID:
31235451
5.

[Relationship between vaping and smoking among 15-year-olds in high school. Results of a descriptive cross-sectional and monocentric observational study conducted in the metropolitan area of Saint-Étienne].

Denis-Vatant C, Merieux C, Leclerc L, Duc H, Berton C, Jarrige R, Nekaa M, Vergnon JM, Pourchez J.

Rev Mal Respir. 2019 Sep;36(7):850-860. doi: 10.1016/j.rmr.2019.04.002. Epub 2019 Jun 13. French.

PMID:
31202601
6.

Implementation of a self-administered questionnaire to detect lung carcinogens.

Pelissier C, Kalecinski J, Brochaye S, Tissot C, Vergnon JM, Fournel P, Chauvin F.

Occup Med (Lond). 2019 Jun 24;69(4):266-271. doi: 10.1093/occmed/kqz065.

PMID:
31051041
7.

Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.

Brun C, Gay P, Cottier M, Karpathiou G, Patoir A, Tiffet O, Barral FG, Vergnon JM, Froudarakis ME.

J Thorac Dis. 2018 Dec;10(12):6903-6911. doi: 10.21037/jtd.2018.11.127.

8.

[Nivolumab and sarcoid reaction in lung cancer treatment].

Vergnon JM, Tissot CL.

Rev Mal Respir. 2019 Feb;36(2):230-232. doi: 10.1016/j.rmr.2019.01.002. Epub 2019 Feb 10. French. No abstract available.

PMID:
30745234
9.

Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB).

Chouaid C, Salaün M, Gounant V, Febvre M, Vergnon JM, Jouniaux V, Fournier C, Lachkar S, Hermant C, Raspaud C, Quantin X, Quiot JJ, Molard A, Dayen C, Marquette CH, Lena H, Zalcman G, Thiberville L.

PLoS One. 2019 Jan 7;14(1):e0208992. doi: 10.1371/journal.pone.0208992. eCollection 2019.

10.

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.

Perotin JM, Leroy S, Marquette CH, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Barbe C, Deslee G; REVOLENS Study Group.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3645-3649. doi: 10.2147/COPD.S176366. eCollection 2018.

11.

High-fidelity simulation self-training enables novice bronchoscopists to acquire basic bronchoscopy skills comparable to their moderately and highly experienced counterparts.

Veaudor M, Gérinière L, Souquet PJ, Druette L, Martin X, Vergnon JM, Couraud S.

BMC Med Educ. 2018 Aug 7;18(1):191. doi: 10.1186/s12909-018-1304-1.

12.

Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I; REVOLENS study group.

Respir Res. 2018 May 9;19(1):84. doi: 10.1186/s12931-018-0796-x.

13.

A method for the quantitative extraction of gold nanoparticles from human bronchoalveolar lavage fluids through a glycerol gradient.

Bitounis D, Barnier V, Guibert C, Pourchez J, Forest V, Boudard D, Hochepied JF, Chelle P, Vergnon JM, Cottier M.

Nanoscale. 2018 Feb 8;10(6):2955-2969. doi: 10.1039/c7nr04484d.

PMID:
29372197
14.

Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.

Deslée G, Leroy S, Perotin JM, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dury S, Benzaquen J, Bonnaire M, Dukic S, Barbe C, Marquette CH; , on behalf of the REVOLENS Study Group13; REVOLENS Study Group.

Eur Respir J. 2017 Dec 21;50(6). pii: 1701740. doi: 10.1183/13993003.01740-2017. Print 2017 Dec. No abstract available.

15.

Deposition pattern of aerosolized Legionella using an ex vivo human-porcine respiratory model.

Perinel S, Forest V, Landraud M, Pourchez J, Girardot F, Riffard S, Stauffert M, Vergnon JM, Allegra S.

Int J Hyg Environ Health. 2018 Mar;221(2):252-259. doi: 10.1016/j.ijheh.2017.11.002. Epub 2017 Nov 20.

PMID:
29174976
16.

Metal load assessment in patient pulmonary lavages: towards a comprehensive mineralogical analysis including the nano-sized fraction.

Forest V, Vergnon JM, Guibert C, Bitounis D, Leclerc L, Sarry G, Pourchez J.

Nanotoxicology. 2017 Nov - Dec;11(9-10):1211-1224. doi: 10.1080/17435390.2017.1406170. Epub 2017 Nov 25.

PMID:
29172825
17.

EBUS-TBNA Can Distinguish Sarcoid-Like Side Effect of Nivolumab Treatment from Tumor Progression in Non-Small Cell Lung Cancer.

Lainez S, Tissot C, Cottier M, Vergnon JM.

Respiration. 2017;94(6):518-521. doi: 10.1159/000480155. Epub 2017 Sep 15.

18.

Biological Monitoring of Inhaled Nanoparticles in Patients: An Appealing Approach To Study Causal Link between Human Respiratory Pathology and Exposure to Nanoparticles.

Forest V, Vergnon JM, Pourchez J.

Chem Res Toxicol. 2017 Sep 18;30(9):1655-1660. doi: 10.1021/acs.chemrestox.7b00192. Epub 2017 Sep 8.

PMID:
28853857
19.

Endobronchial melanoma metastasis 40 years after the excision of the primary cutaneous tumor: A case report.

Karpathiou G, Froudarakis M, Da Cruz V, Forest F, Sauvage M, Vergnon JM, Peoc'h M.

Medicine (Baltimore). 2017 Aug;96(34):e7931. doi: 10.1097/MD.0000000000007931.

20.

An extremely rare case of postpartum gestational choriocarcinoma with long-term survival.

Vincent M, Court-Fortune I, Karpathiou G, Froudarakis ME, Vergnon JM.

Tumori. 2017 Nov 15;103(Suppl. 1):e16-e18. doi: 10.5301/tj.5000660.

PMID:
28777426
21.

Nicotine delivery from the refill liquid to the aerosol via high-power e-cigarette device.

Prévôt N, de Oliveira F, Perinel-Ragey S, Basset T, Vergnon JM, Pourchez J.

Sci Rep. 2017 Jun 1;7(1):2592. doi: 10.1038/s41598-017-03008-0.

22.

Frozen Sections in Pleural Pathology: A Valuable Tool.

Karpathiou G, Froudarakis M, Forest F, Mobarki M, Patoir A, Gay P, Vergnon JM, Tiffet O, Peoc'h M.

Respiration. 2017;94(1):45-51. doi: 10.1159/000474952. Epub 2017 May 6.

23.

Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies.

Habougit C, Trombert-Paviot B, Karpathiou G, Casteillo F, Bayle-Bleuez S, Fournel P, Vergnon JM, Tiffet O, Péoc'h M, Forest F.

Virchows Arch. 2017 Jun;470(6):639-646. doi: 10.1007/s00428-017-2109-z. Epub 2017 Mar 27.

PMID:
28349237
24.

Development of an ex vivo human-porcine respiratory model for preclinical studies.

Perinel S, Pourchez J, Leclerc L, Avet J, Durand M, Prévôt N, Cottier M, Vergnon JM.

Sci Rep. 2017 Feb 24;7:43121. doi: 10.1038/srep43121.

25.

Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF.

Gay P, Wallaert B, Nowak S, Yserbyt J, Anevlavis S, Hermant C, Lovis A, Menard O, Maitre B, Vandemoortele T, Dutau H, Briault A, Bourdin A, Vergnon JM, Froudarakis ME; Groupe d''Endoscopie Thoracique de Langue Française.

Respiration. 2017;93(3):198-206. doi: 10.1159/000455179. Epub 2017 Jan 21.

26.

Assessment of new-generation high-power electronic nicotine delivery system as thermal aerosol generation device for inhaled bronchodilators.

Pourchez J, de Oliveira F, Perinel-Ragey S, Basset T, Vergnon JM, Prévôt N.

Int J Pharm. 2017 Feb 25;518(1-2):264-269. doi: 10.1016/j.ijpharm.2017.01.009. Epub 2017 Jan 4.

PMID:
28062365
27.

Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model.

Perinel S, Leclerc L, Prévôt N, Deville A, Cottier M, Durand M, Vergnon JM, Pourchez J.

Respir Res. 2016 Jul 7;17(1):78. doi: 10.1186/s12931-016-0395-7.

28.

[Bench-test evaluation of spacer devices for fluticasone delivery to infants].

Pourchez J, Leclerc L, Sarry G, Vergnon JM, Dubus JC.

Rev Mal Respir. 2017 Jan;34(1):29-35. doi: 10.1016/j.rmr.2016.02.009. Epub 2016 May 5. French.

PMID:
27155896
29.

Respiratory Conditions Associated with Tracheobronchomegaly (Mounier-Kuhn Syndrome): A Study of Seventeen Cases.

Schmitt P, Dalar L, Jouneau S, Toublanc B, Camuset J, Chatte G, Cellerin L, Dutau H, Sanchez S, Sauvage M, Vergnon JM, Dury S, Deslée G, Lebargy F; Groupe d''Endoscopie de Langue Française (GELF).

Respiration. 2016;91(4):281-7. doi: 10.1159/000445029. Epub 2016 Mar 25.

30.

Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies.

Forest F, Yvorel V, Karpathiou G, Stachowicz ML, Vergnon JM, Fournel P, Tiffet O, Trombert B, Péoc'h M.

Hum Pathol. 2016 Mar;49:99-106. doi: 10.1016/j.humpath.2015.10.006. Epub 2015 Nov 2.

PMID:
26826416
31.

Endobronchial metastases from melanoma: a survival analysis.

Chaussende A, Hermant C, Tazi-Mezalek R, Favrolt N, Hureaux J, Fournier C, Lorut C, Paganin F, Ngo MT, Vandemoortele T, Anevlavis S, Froudarakis ME, Vergnon JM.

Clin Respir J. 2017 Nov;11(6):1006-1011. doi: 10.1111/crj.12456. Epub 2016 Feb 25.

PMID:
26789129
32.

41 years into the bronchial tree: a very obstructive cap.

Pellissier A, Kebdani S, Lacheheb M, Lainez S, Froudarakis ME, Vergnon JM.

Clin Respir J. 2017 Nov;11(6):1060-1062. doi: 10.1111/crj.12443. Epub 2016 Feb 18.

PMID:
26763152
33.

Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.

Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group.

JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821.

PMID:
26757466
34.

[Foreign body of dental origin: How to retrieve the dentist's drill?].

Vincent M, Vergnon JM.

Rev Mal Respir. 2016 Jan;33(1):63-6. doi: 10.1016/j.rmr.2015.06.016. Epub 2015 Jul 29. French.

PMID:
26232208
35.

[3rd French day of idiopathic pulmonary fibrosis. September 19, 2014].

Cottin V, Crestani B, Danel C, Debray MP, Nunes H, Poletti V, Prévost G, Vergnon JM, Wallaert B, Cordier JF.

Rev Pneumol Clin. 2015 Aug;71(4):189-206. doi: 10.1016/j.pneumo.2015.06.002. Epub 2015 Jul 29. French. No abstract available.

PMID:
26232107
36.

[Tracheobronchial prosthesis in Mounier-Kuhn syndrome: New perspectives].

Sauvage M, Tiffet O, Vergnon JM.

Rev Mal Respir. 2015 May;32(5):519-23. doi: 10.1016/j.rmr.2015.02.003. Epub 2015 Feb 27. French.

PMID:
25737189
37.

Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis.

Oliva A, Flori P, Hennequin C, Dubus JC, Reynaud-Gaubert M, Charpin D, Vergnon JM, Gay P, Colly A, Piarroux R, Pelloux H, Ranque S.

J Clin Microbiol. 2015 Jan;53(1):248-54. doi: 10.1128/JCM.02690-14. Epub 2014 Nov 12.

38.

Complete resolution of cerebral air embolism secondary to a transbronchial needle aspiration.

Perinel Ragey S, Garnier P, Vergnon JM.

Respiration. 2013;86(6):504-7. doi: 10.1159/000354790. Epub 2013 Nov 23.

39.

A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantation: the MDS classification.

Dutau H, Vandemoortele T, Laroumagne S, Gomez C, Boussaud V, Cavailles A, Cellerin L, Colchen A, Degot T, Gonin F, Hermant C, Jougon J, Kessler R, Philit F, Pison C, Saint Raymond C, Wermert D, Astoul P, Thomas P, Reynaud-Gaubert M, Vergnon JM.

Eur J Cardiothorac Surg. 2014 Feb;45(2):e33-8. doi: 10.1093/ejcts/ezt499. Epub 2013 Nov 7.

PMID:
24212769
40.

Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy.

Valipour A, Herth FJ, Burghuber OC, Criner G, Vergnon JM, Goldin J, Sciurba F, Ernst A; VENT Study Group.

Eur Respir J. 2014 Feb;43(2):387-96. doi: 10.1183/09031936.00133012. Epub 2013 Jul 11.

41.

[Interest for evaluation of bronchial inflammation in asthma].

Glas N, Vergnon JM, Pacheco Y.

Rev Pneumol Clin. 2013 Apr;69(2):76-82. doi: 10.1016/j.pneumo.2012.10.004. Epub 2013 Feb 19. Review. French.

PMID:
23434035
42.

[Cost-effectiveness of lung volume reduction coil treatment in emphysema. STIC REVOLENS].

Deslee G, Barbe C, Bourdin A, Durand-Zaleski I, Dutau H, Jolly D, Jounieaux V, Kessler R, Mal H, Pison C, Thiberville L, Vergnon JM, Marquette CH.

Rev Mal Respir. 2012 Nov;29(9):1157-64. doi: 10.1016/j.rmr.2012.09.010. Epub 2012 Oct 12. French.

PMID:
23200592
43.

[Interventional bronchoscopy: choosing the right tool].

Vergnon JM.

Rev Mal Respir. 2012 Nov;29(9):1077-8. doi: 10.1016/j.rmr.2012.09.011. Epub 2012 Oct 12. French. No abstract available.

PMID:
23200578
44.

In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.

Salaün M, Roussel F, Bourg-Heckly G, Vever-Bizet C, Dominique S, Genevois A, Jounieaux V, Zalcman G, Bergot E, Vergnon JM, Thiberville L.

Eur Respir J. 2013 Dec;42(6):1646-58. doi: 10.1183/09031936.00191911. Epub 2012 Sep 27.

45.

[Non-small cell carcinoma presenting as limbic encephalitis. Place of endobronchial ultrasound in the diagnosis].

Morelli-Zaher C, Varvat J, Duboeuf F, Antoine JC, Vergnon JM.

Rev Mal Respir. 2012 May;29(5):719-22. doi: 10.1016/j.rmr.2011.12.019. Epub 2012 Apr 20. French.

PMID:
22682599
46.

Bronchoalveolar lavage in hypersensitivity pneumonitis: a series of 139 patients.

Caillaud DM, Vergnon JM, Madroszyk A, Melloni BM, Murris M, Dalphin JC; French Group of Environmental Immunoallergic Bronchopulmonary Diseases.

Inflamm Allergy Drug Targets. 2012 Feb;11(1):15-9.

PMID:
22309080
47.

[Possibility to screen COPD in emergency department].

Vial M, Apelt P, Cavalli P, Guerin T, Vercherin P, Vergnon JM.

Rev Pneumol Clin. 2012 Feb;68(1):10-6. doi: 10.1016/j.pneumo.2011.06.009. Epub 2011 Aug 25. French.

PMID:
22305132
48.

Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort.

Herth FJ, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, Egan JJ, Gasparini S, Agusti C, Holmes-Higgin D, Ernst A; International VENT Study Group.

Eur Respir J. 2012 Jun;39(6):1334-42. doi: 10.1183/09031936.00161611. Epub 2012 Jan 26.

49.

[Nodular presentation of a cryptogenic organizing pneumonia].

Marques G, Annweiler T, Raoux D, Tiffet O, Vergnon JM, Bertoletti L.

Rev Pneumol Clin. 2011 Oct;67(5):314-7. doi: 10.1016/j.pneumo.2010.06.004. Epub 2010 Dec 3. French.

PMID:
22017952
50.

[Managements of chronic cough in general medicine and requirements of general practitioners].

Chomette-Ballereau S, Bertoletti L, Glas N, Frappé P, Costes F, Vergnon JM.

Rev Pneumol Clin. 2012 Jun;68(3):171-9. doi: 10.1016/j.pneumo.2011.07.003. Epub 2011 Oct 19. French.

PMID:
22014768

Supplemental Content

Loading ...
Support Center